Thursday, June 10, 2021 5:05:37 PM
"We need to constantly be surveilling for these new variants and we need to be developing Covid therapeutics that will rescue people who get Covid even in the face of the vaccination programs."
- Dr. Jonathan Javitt, CEO of NRx and adjunct professor at Johns Hopkins School of Medicine, told Fox News.
https://www.foxnews.com/health/lag-covid-19-vaccine-boosters-variants-therapeutics
There is no shortage of bio companies with ill equipped management. I do not think RLF/NRX would fall into that group though. They are all well seasoned and veterans of big pharma and bio companies, they know the game and have a financial interest just like we do. Say what you want but these are guys I am invested with. I got JJ, I got Ram, I got GEM... Those are my business partners and they ALL bring an area of expertise to the table. I am still not convinced Ram doesn't have a list of company's to acquire and we are just getting started on the A's of it.
There is plenty of scientific literature with empirical evidence on peptide function in mammals. A wealth of those show the benefits of VIP specifically and appear to offer potentially new treatment for a wide array of ailments. Safety & Efficacy seem to be a given at this point. The results already have been speaking for themselves. RLF/NRX are doing this without some BP "sponsor" because they are all extremely well equipped with the nuances and kid gloves that are required with the US FDA.
Best,
JB
“The stock market is a device for transferring money from the impatient to the patient”
-Warren Buffett
Disclaimer
All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • Oct 1, 2024 7:00 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM
BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM